|
ALZN Alzamend Neuro Inc 1677077 |
| Income Statement |
|
Net Income
|
z3425010q
|
-1,415,214 |
| Balance Sheet |
|
Current Assets
|
4,766,742 |
|
Assets
|
5,007,718 |
|
Current Liabilities
|
3,826,457 |
|
Liabilities
|
1,254,750 |
|
Equity
|
3,752,968 |
|
Shares Out
|
3,890,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-4,455,843 |
|
Investing Cash Flow
|
-90,000 |
| Market Analysis |
Market Cap
|
6,729,807 |
|
Price
|
0.94 |
|
BVPS
|
0.96 |
|
PB
|
0.98 |
|
EPS
|
-10.69 |
|
PS
|
55.03 |
|
FCF
|
-4,545,843 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ALZN documents filed with the SEC.
ALZN Filings
Clear
